BriaCell Therapeutics Corp.

NASDAQ (USD): BriaCell Therapeutics Corp. (BCTX)

Last Price

0.561

Today's Change

-0.024 (4.10%)

Day's Change

0.561 - 0.624

Trading Volume

902,313

Profile
BCTX

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. William V. Williams M.D. Dr. William V. Williams M.D.

Full Time Employees:  16 16

IPO Date:  2012-03-14 2012-03-14

CIK:  0001610820 0001610820

ISIN:  CA1079301091 CA1079301091

CUSIP:  10778Y302 10778Y302

Beta:  1.82 1.82

Last Dividend:  0.00 0.00

Dcf Diff:  0.52 0.52

Dcf:  0.04 0.04

Description

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Address

Bellevue Centre,
West Vancouver, BC V7T 2X1, CA

604 921 1810

http://www.briacell.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment